Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study.

Wung SF, Aouizerat BE.

Biol Res Nurs. 2008 Apr;9(4):280-92. doi: 10.1177/1099800407313385.

PMID:
18398223
2.

Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population.

Sayers I, Barton S, Rorke S, Sawyer J, Peng Q, Beghé B, Ye S, Keith T, Clough JB, Holloway JW, Sampson AP, Holgate ST.

Clin Exp Allergy. 2003 Aug;33(8):1103-10.

PMID:
12911785
3.

5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer.

Wang J, John EM, Ingles SA.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2748-54. doi: 10.1158/1055-9965.EPI-08-0439.

4.

Influence of leukotriene gene polymorphisms on chronic rhinosinusitis.

Al-Shemari H, Bossé Y, Hudson TJ, Cabaluna M, Duval M, Lemire M, Vallee-Smedja S, Frenkiel S, Desrosiers M.

BMC Med Genet. 2008 Mar 26;9:21. doi: 10.1186/1471-2350-9-21.

5.

Impact of matrix metalloproteinase-1 gene variations on risk of acute coronary syndrome.

Han Y, Wu Z, Zhang X, Yan C, Xi S, Yang Y, Pei F, Kang J.

Coron Artery Dis. 2008 Jun;19(4):227-30. doi: 10.1097/MCA.0b013e3282f9d3d8.

PMID:
18480665
6.

Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease.

Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Fortmann SP, Go A, Hlatky M, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T.

Hum Genet. 2008 May;123(4):399-408. doi: 10.1007/s00439-008-0489-5. Epub 2008 Mar 28.

7.

Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients.

Fragoso JM, Vallejo M, Alvarez-León E, Delgadillo H, Peña-Duque MA, Cardoso-Saldaña G, Posadas-Romero C, Martínez-Ríos MA, Vargas-Alarcón G.

Cytokine. 2011 Jul;55(1):29-33. doi: 10.1016/j.cyto.2011.03.021. Epub 2011 Apr 9.

PMID:
21481602
8.

PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.

Kostulas K, Gretarsdottir S, Kostulas V, Manolescu A, Helgadottir A, Thorleifsson G, Gudmundsson LJ, Thorsteinsdottir U, Gulcher JR, Stefansson K, Hillert J.

J Neurol Sci. 2007 Dec 15;263(1-2):113-7. Epub 2007 Jul 25.

PMID:
17655870
9.

R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome.

Gao LB, Zhou B, Zhang L, Wei YS, Wang YY, Liang WB, Lv ML, Pan XM, Chen YC, Rao L.

BMC Med Genet. 2008 Jul 30;9:74. doi: 10.1186/1471-2350-9-74.

10.

Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.

Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8.

11.
12.

ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.

Girelli D, Martinelli N, Trabetti E, Olivieri O, Cavallari U, Malerba G, Busti F, Friso S, Pizzolo F, Pignatti PF, Corrocher R.

Eur J Hum Genet. 2007 Sep;15(9):959-66. Epub 2007 May 16.

13.

Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome.

Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y.

Int J Mol Med. 2008 Jun;21(6):801-8.

PMID:
18506375
14.

Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome.

Jiang L, Liu CY, Yang QF, Wang P, Zhang W.

Am J Clin Pathol. 2009 May;131(5):738-43. doi: 10.1309/AJCP3CX3AUVRBHCF.

PMID:
19369636
15.
16.

Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.

Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, Pasdar A, Grant SF, Whalley LJ, Hakonarson H, Thorsteinsdottir U, Kong A, Gulcher J, Stefansson K, MacLeod MJ.

Am J Hum Genet. 2005 Mar;76(3):505-9. Epub 2005 Jan 7.

17.

ALOX5 variants associated with susceptibility to human pulmonary tuberculosis.

Herb F, Thye T, Niemann S, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Werz O, Rüsch-Gerdes S, Horstmann RD, Meyer CG.

Hum Mol Genet. 2008 Apr 1;17(7):1052-60. doi: 10.1093/hmg/ddm378. Epub 2008 Jan 3.

PMID:
18174194
18.

[Association of the ALOX5AP gene SG13S114 A/T polymorphism with atherosclerosis].

He YL, Jin XP, Zhu M, Lin XF, Xie ZL, Chen QY.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Apr;27(2):186-9. doi: 10.3760/cma.j.issn.1003-9406.2010.02.015. Chinese.

PMID:
20376802
19.

Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study.

Domingues-Montanari S, Fernández-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, Gouveia L, Sobral J, Mendioroz M, Fernández-Morales J, Alvarez-Sabin J, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Ferro JM, Vicente AM, Oliveira SA, Montaner J.

Cerebrovasc Dis. 2010;29(6):528-37. doi: 10.1159/000302738. Epub 2010 Mar 30.

PMID:
20357438
20.

Association of ALOX5AP haplotypes with susceptibility to coronary artery disease in a Chinese Han population.

Li Y, Li Z, Zhang X, Yan C, Kang J, Liang Z, Liu S, Feng X, Han Y.

Eur J Intern Med. 2012 Jul;23(5):e119-23. doi: 10.1016/j.ejim.2012.02.010. Epub 2012 Mar 14.

PMID:
22726381

Supplemental Content

Support Center